Compare peptides

Put two entries side by side — evidence, mechanism, risks, and community claims.

GHRP-2

Limited
Research chemical
Summary
Potent GH-releasing peptide; stronger hunger and prolactin/cortisol effects than Ipamorelin.
Categories
Growth Hormone Axis, Performance
Mechanism
Ghrelin receptor agonist amplifying pituitary GH release.
Half-life
~30 minutes
Routes
Subcutaneous injection; Intranasal
Legal / access
Not approved for anti-aging or bodybuilding use.
Key risks
  • Strong hunger
  • Water retention
  • Elevated cortisol/prolactin (possible)
  • Flushing
Common claims
  • Stronger GH pulse than Ipamorelin
  • Useful during aggressive recomp phases
  • Stacking with GHRH analogs for maximum output
Select peptide B